# Quantum Interference Enhanced Rectification in Mesoscopic Nanowires

Preprint · T. J. Osborne, B. Braunecker, H. F. Legg

- Archive id: arxiv:2610.29484
- Published: 2026-10-21
- arXiv: https://arxiv.org/abs/2610.29484
- Citations: 0
- Source URL: https://arxiv.org/abs/2610.29484
- PDF: https://arxiv.org/pdf/2610.29484
- Provenance: arxiv

## Abstract

Nanoscale nonreciprocal elements are needed to control signal flow in scalable quantum technologies, but existing nonreciprocal components are often bulky. Here, we show that a strongly nonreciprocal current-voltage relation can arise entirely from coherent elastic scattering in a mesoscopic Rashba nanowire with gate-defined scatterers. We first identify the symmetry constraints that enforce reciprocal transmission in a phase coherent conductor even when inversion and time-reversal symmetry are broken. We then show how gates that are capacitively coupled to the leads, together with a magnetic scatterer or transverse subband mixing, can remove these constraints. In the weak-scattering regime, nonreciprocal conductance originates from interference between distinct backscattering paths. In the strong-scattering regime, nonreciprocity can be resonantly enhanced by the hybridization of the transmitting channel with bound states that arise from a higher transverse subband or spin-split band. In this regime, we find that a bias-induced change in the gate potentials of about one percent can produce an order-unity diode response, i.e., electrons are transmitted almost as in a clean wire for one bias polarity, whereas for the other polarity the current is strongly suppressed.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Topological Superconductivity & Majorana Modes](https://space-kitty.com/topics/topological-superconductivity)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.